ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645621 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645621; 2) Community: the network communities that were significantly associated with the response to NSC 645621; 3) Molecule: the relationships between components within communities and NSC 645621; 4) MDR: the compounds that were significantly associated with the NSC 645621.

NSC Compound Enrichment Correlation
NSC 701574 Androst-4-en-3-one, 17-ethynyl-17-hydroxy-, 3-O-[2-(1-pyrrolidinyl)ethyl]oxime, (17.beta.)- 0.00550789647802199 0.4463902
NSC 719415 Null 0.00550789647802199 -0.095784486
NSC 343378 1H-Indene-1,3(2H)-dione, 2-[[(2-methylphenyl)imino]phenylmethyl]- 0.00581536684273141 0.28596603
NSC 711079 Null 0.00581536684273145 0.05248243
NSC 752329 (Z)-6-(2-(pyridin-2-ylmethylene)hydrazinyl)-9H-purine 0.00581536684273145 -0.044539964
NSC 756193 GSK978744A 0.00581536684273145 0.39799064
NSC 138780 8-(3-Methylbutyryloxy)diacetoxyscirpenol 0.00626092470586549 0.25524696
NSC 685989 Dihydroartemisinyl ether, stereoisomer of NSC-685988 0.00626092470586549 0.32091593
NSC 131888 Null 0.00662388971299133 0.20894967
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.00662388971299133 0.67688064
Total:56  Current:7    [First] [Prev] [Next] [Last]